| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |